Deferoxamine
Deferoxamine is a clinically used iron chelator for treating acute iron toxicity and a research tool for studying iron metabolism. It is widely applied in neuroscience, oncology, and immunology research, demonstrating efficacy in models of traumatic brain injury, cancer cell death (apoptosis/autophagy), and inflammation, both in vitro and in vivo.
Product Specifications
CAS Number
70-51-9
Product Name Alternative
Antioxidant, Apoptosis, Autophagy, Desferrioxamine B, Deferoxamine, Deferoxamine B, HIF
Field of Research
Purity
99.66% (May vary between batches)
Solubility
DMSO: 12.4 mg/mL (22.12 mM), sonication and heating are recommended. H2O: 7.14 mg/mL (12.73 mM), sonication is recommended.
Smiles
O=C (NCCCCCN (O) C (=O) C) CCC (=O) N (O) CCCCCNC (=O) CCC (=O) N (O) CCCCCN
Molecular Formula
C25H48N6O8
Molecular Weight
560.68
Storage Conditions
Powder: -20°C for 3 years. In solvent: -80°C for 1 year.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Uncoated Human CD48 (CD48 antigen) ELISA Kit
Uncoated Human CD48 (CD48 antigen) ELISA Kit
Trichloroethyl Beta-D-Glucuronide Potassium Salt
Napsin-A (NAPSA/1239), CF647 conjugate, 0.1mg/mL
